Bayesian Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.04M | Buy |
|
|||||
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $3.32M | Buy |
|
|||||
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $502K | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $206K | Buy |
|
|||||
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $273K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $1.55M | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $1.06M | Sell |
|
|||||
2020
Q1 | $1.11M | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $302K | Sell |
|
|||||
2019
Q1 | $701K | Buy |
|
|||||
2017
Q2 | – | Sell |
|
|||||
2017
Q1 | $591K | Buy |
|